This country profile provides an overview of Eritrea’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profiles

Treatment coverage

Elephantiasis
76%
Blinding trachoma
69%
Intestinal worms
N/A
Bilharzia
50%
River blindness
N/A
0.74 million people received treatment in Eritrea in 2017 0.33 million people did not receive treatment in Eritrea in 2017

Priorities for progress in Eritrea

  • Eritrea is encouraged to work to maintain treatment coverage levels for elephantiasis and trachoma, whilst increasing treatment coverage for bilharzia in school age children.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Treatment coverage increased from 31% in 2016 to 76% in 2017.

People needing treatment
0.07m
People receiving treatment
0.06m

Blinding trachoma

Treatment coverage increased from 18% in 2016 to 69% in 2017.

People needing treatment
1.08m
People receiving treatment
0.74m

Intestinal worms

Eritrea does not require mass treatment for intestinal worms.

Bilharzia

Treatment coverage decreased from 53% in 2016 to 50% in 2017.

School-aged children needing treatment
0.18m
School-aged children receiving treatment
0.09m

River blindness

Eritrea does not require mass treatment for river blindness.

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Eritrea.